Olaparib
Back to searchMolecule Structure
Scientific Name
Olaparib
Description of the Drug
Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09074
http://www.drugbank.ca/drugs/DB09074
Brand Name(s)
Lynparza
Company Owner(s)
Astrazeneca Pharmaceuticals Lp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
PARP 1, 2 and 3 | PROTEIN FAMILY | INHIBITOR | CHEMBL3390820 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL426568 | |
Human Metabolome Database | HMDB0255929 | |
DrugBank | DB09074 | |
PubChem: Thomson Pharma | 47209066 | |
PubChem | 23725625 | |
LINCS | LSM-1145 | |
Nikkaji | J2.765.098H | |
PDBe | 09L | |
BindingDB | 27566 | |
DrugCentral | 4907 | |
Brenda | 209563 | |
ChemicalBook | CB02473811 | CB02756176 |
Guide to Pharmacology | 7519 | |
rxnorm | OLAPARIB | LYNPARZA |
PubChem: Drugs of the Future | 85197660 | |
ChEBI | 83766 | |
ZINC | ZINC000040430143 |